Detalles de la búsqueda
1.
Toll-like receptor 3 agonist poly I:C reinforces the potency of cytotoxic chemotherapy via the TLR3-UNC93B1-IFN-ß signaling axis in paclitaxel-resistant colon cancer.
J Cell Physiol
; 234(5): 7051-7061, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30387134
2.
Case fatality rate of the adult in-patients with COVID-19 and digestive system tumors: A systematic review and meta-analysis.
Medicine (Baltimore)
; 101(25): e29364, 2022 Jun 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35758367
3.
Current Progress and Future Perspectives of Immune Checkpoint Inhibitors in Biliary Tract Cancer.
Onco Targets Ther
; 14: 1873-1882, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33737812
4.
Study on Efficacy and Safety of Low-Dose Apatinib Combined with Camrelizumab and SOX Regimen as First-Line Treatment of Locally Advanced and Unresectable Gastric/Gastroesophageal Junction Cancer: A Protocol for an Open-Label, Dose Escalation and Extension Phase Ib Clinical Trial.
Onco Targets Ther
; 14: 4859-4865, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34584426
5.
Ferumoxytol and CpG oligodeoxynucleotide 2395 synergistically enhance antitumor activity of macrophages against NSCLC with EGFRL858R/T790M mutation.
Int J Nanomedicine
; 14: 4503-4515, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31417255
6.
CUX1-ALK, a Novel ALK Rearrangement That Responds to Crizotinib in Non-Small Cell Lung Cancer.
J Thorac Oncol
; 13(11): 1792-1797, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30010043
7.
Anti-tumor macrophages activated by ferumoxytol combined or surface-functionalized with the TLR3 agonist poly (I : C) promote melanoma regression.
Theranostics
; 8(22): 6307-6321, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30613299
Resultados
1 -
7
de 7
1
Próxima >
>>